Concomitantly, the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathways have been shown to be activated in most melanomas. The gene discussed is AKT1; the disease is melanoma.